64
Participants
Start Date
March 1, 2021
Primary Completion Date
March 2, 2023
Study Completion Date
March 13, 2023
Epidiolex 100 mg/mL Oral Solution
Cannabidiol (CBD): is the primary non-psychoactive and non-addictive compound in cannabis, has already shown potential in treating pain such as arthritis, neuropathic, cancer and chronic pain
Placebo
Placebo drug will be a solution with the same taste, texture and color as the drug.
The University of Texas Health Science Center at San Antonio, San Antonio
The University of Texas Health Science Center at San Antonio
OTHER